An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.
Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...
Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...
This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...
Zacks Investment Research on MSN
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test
Quanterix QTRX recently announced the submission of a 510(k) premarket notification to the FDA for its multi-analyte ...
A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week. The diagnostic tool, the Elecsys pTau 181 plasma test, is developed by ...
During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...
WYFF News 4 on MSN
Upstate experts celebrate milestone in Alzheimer's, dementia research
An international study has confirmed that at-home blood collection in the form of a finger-prick test can accurately ...
Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...
Topeka's Cotton O'Neil is using a new, early diagnosis tool to test new Alzheimer's treatments.
When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results